Covered recipient · General Payments record
DIPA RAVAL
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$730.06
- Reported across 29 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $299.72 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Exact Sciences Corporation | $65.74 | 2 |
| Novo Nordisk AS | $63.46 | 3 |
| Acerta Pharma LLC | $53.66 | 3 |
| PFIZER INC. | $39.67 | 2 |
| ABBVIE INC. | $34.04 | 1 |
| Amgen Inc. | $24.81 | 1 |
| Lilly USA, LLC | $18.34 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $34.04 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105387286 | CMS |
| Amgen Inc. | $24.81 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111685162 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.31 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104620050 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.45 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104767296 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.90 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105385079 | CMS |
| Exact Sciences Corporation | $30.81 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114848571 | CMS |
| Exact Sciences Corporation | $34.93 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114848577 | CMS |
| Lilly USA, LLC | $18.34 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136168258 | CMS |
| Novo Nordisk Inc | $21.40 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097532282 | CMS |
| Novo Nordisk Inc | $18.80 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097009523 | CMS |
| Novo Nordisk Inc | $23.26 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096588551 | CMS |
| PFIZER INC. | $15.24 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130924595 | CMS |
| PFIZER INC. | $24.43 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131151767 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.